Cargando…
The Polypill: From Promise to Pragmatism
Mark Huffman asks what happened to the polypill to reduce cardiovascular risk, explores the promise it still holds, and considers how best to turn promise into reality.
Autor principal: | Huffman, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532495/ https://www.ncbi.nlm.nih.gov/pubmed/26263422 http://dx.doi.org/10.1371/journal.pmed.1001862 |
Ejemplares similares
-
Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016) -
Vaccination to prevent human papillomavirus infections: From promise to practice
por: Bloem, Paul, et al.
Publicado: (2017) -
Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011) -
The Rise of Consumer Health Wearables: Promises and Barriers
por: Piwek, Lukasz, et al.
Publicado: (2016) -
Precision medicine and monoclonal antibodies: breach of promise?
por: Garattini, Livio, et al.
Publicado: (2019)